UK markets close in 1 hour 18 minutes

Ironwood Pharmaceuticals, Inc. (IRWD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.080.00 (0.00%)
As of 10:12AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-1,002,239
-1,002,239
175,065
528,448
106,176
Depreciation & amortisation
1,600
1,600
1,400
1,500
3,564
Deferred income taxes
72,637
72,637
65,739
-333,294
0
Stock-based compensation
32,005
32,005
27,048
22,281
31,175
Change in working capital
11,279
11,279
2,820
17,731
-941
Accounts receivable
924
924
7,993
7,712
4,091
Inventory
-
-
0
0
648
Accounts payable
12,380
12,380
-8,116
-2,644
-7,523
Other working capital
183,154
183,154
273,627
261,630
166,994
Other non-cash items
1,097,484
1,097,484
1,871
23,958
22,263
Net cash provided by operating activities
183,427
183,427
273,763
261,895
168,836
Cash flows from investing activities
Investments in property, plant and equipment
-273
-273
-136
-265
-1,842
Acquisitions, net
-1,026,045
-1,026,045
0
0
-
Purchases of investments
-
-
-
-
0
Sales/maturities of investments
-
-
-
-
0
Net cash used for investing activities
-1,026,318
-1,026,318
-136
-265
-1,842
Cash flows from financing activities
Debt repayment
-100,000
-100,000
-120,699
0
0
Common stock repurchased
0
0
-126,394
-24,131
0
Other financing activities
-29,197
-29,197
-
-
-
Net cash used provided by (used for) financing activities
277,160
277,160
-237,553
-4,550
18,546
Net change in cash
-565,784
-565,784
36,074
257,080
185,540
Cash at beginning of period
657,938
657,938
621,864
364,784
179,244
Cash at end of period
92,154
92,154
657,938
621,864
364,784
Free cash flow
Operating cash flow
183,427
183,427
273,763
261,895
168,836
Capital expenditure
-273
-273
-136
-265
-1,842
Free cash flow
183,154
183,154
273,627
261,630
166,994